Alivus Life Sciences Share Price
1386.10-32.70 (-2.30%)
+47.87% past 1 Year
News
Alivus Life Sciences to acquire 76 percent stake in Iqgen-X Pharma
Equity
ALIVUS
Alivus Life Sciences Q1 EBITDA grows with strong margin expansion YoY
Equity
ALIVUS
Alivus Life Sciences reports strong Q1 revenue growth of 6.7 percent YoY
Equity
ALIVUS
Alivus Life Sciences Q1 net profit rises 33 percent year-on-year
Equity
ALIVUS
Alivus Life Sciences to host Q1 FY27 earnings conference call on July 31
Equity
ALIVUS
Alivus Life Sciences Reports Q4 EBITDA Growth to Rs 210 Crores, Margin Expands to 31.13%
Equity
ALIVUS
Alivus Life Sciences Reports Strong Q4FY25 Earnings with Profit and Revenue Growth
Equity
ALIVUS
Alivus Life Sciences reports Profit after tax of 162.66 Crores, in the March 2026 quarter
Equity
ALIVUS
Alivus Life Sciences informs about disclosure
Equity
ALIVUS
Alivus Life Sciences Fire Incident At Dahej: Production Recovery Timeline Announced
Equity
ALIVUS
Alivus Life Sciences informs about updates
Equity
ALIVUS
Fire at Alivus Life Sciences API Plant in Dahej Injures Three; Company Assessing Damages.
Equity
ALIVUS
Alivus Life Sciences Management Guides for Additional CDMO Projects by Q1 FY27, Double-Digit Growth from FY28-29.
Equity
ALIVUS
Alivus Life Sciences Solapur Plant Operations Timeline and Capacity Utilization Guidance
Equity
ALIVUS
Alivus Life Sciences Revises FY26 Capex Guidance Down to INR450 Crores from INR600 Crores.
Equity
ALIVUS
Alivus Life Sciences Raises EBITDA Margin Guidance to 30%-32% from 28%-30% on Efficiencies, Launches.
Equity
ALIVUS
Alivus Life Sciences Guidance: High Single-Digit FY26 Revenue Growth Driven By Non-GPL And CDMO
Equity
ALIVUS
Alivus Life Sciences - Quaterly Results
Equity
ALIVUS
Alivus Life Sciences reports Profit after tax of 150.26 Crores, in the December 2025 quarter
Equity
ALIVUS
Alivus Life Sciences Reports Q3 Revenue Growth to Rs 670 Crores, Up from Rs 642 Crores YoY.
Equity
ALIVUS